Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 260

1.

Combination antiretroviral therapy and duration of pregnancy.

European Collaborative Study.; Swiss Mother and Child HIV Cohort Study..

AIDS. 2000 Dec 22;14(18):2913-20.

PMID:
11398741
2.

Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission.

Cooper ER, Charurat M, Mofenson L, Hanson IC, Pitt J, Diaz C, Hayani K, Handelsman E, Smeriglio V, Hoff R, Blattner W; Women and Infants' Transmission Study Group..

J Acquir Immune Defic Syndr. 2002 Apr 15;29(5):484-94.

PMID:
11981365
3.

Increased rate of prematurity associated with antenatal antiretroviral therapy in a German/Austrian cohort of HIV-1-infected women.

Grosch-Woerner I, Puch K, Maier RF, Niehues T, Notheis G, Patel D, Casteleyn S, Feiterna-Sperling C, Groeger S, Zaknun D; Multicenter Interdisciplinary Study Group Germany/Austria..

HIV Med. 2008 Jan;9(1):6-13. doi: 10.1111/j.1468-1293.2008.00520.x.

PMID:
18199167
4.

Premature delivery in HIV-infected women starting protease inhibitor therapy during pregnancy: role of the ritonavir boost?

Sibiude J, Warszawski J, Tubiana R, Dollfus C, Faye A, Rouzioux C, Teglas JP, Ekoukou D, Blanche S, Mandelbrot L.

Clin Infect Dis. 2012 May;54(9):1348-60. doi: 10.1093/cid/cis198.

PMID:
22460969
5.

Antiretroviral therapies in pregnancy: maternal, fetal and neonatal effects. Swiss HIV Cohort Study, the Swiss Collaborative HIV and Pregnancy Study, and the Swiss Neonatal HIV Study.

Lorenzi P, Spicher VM, Laubereau B, Hirschel B, Kind C, Rudin C, Irion O, Kaiser L.

AIDS. 1998 Dec 24;12(18):F241-7.

PMID:
9875571
6.

Maternal 12-month response to antiretroviral therapy following prevention of mother-to-child transmission of HIV type 1, Ivory Coast, 2003-2006.

Coffie PA, Ekouevi DK, Chaix ML, Tonwe-Gold B, Clarisse AB, Becquet R, Viho I, N'dri-Yoman T, Leroy V, Abrams EJ, Rouzioux C, Dabis F.

Clin Infect Dis. 2008 Feb 15;46(4):611-21. doi: 10.1086/526780.

PMID:
18197758
7.

Is the interruption of antiretroviral treatment during pregnancy an additional major risk factor for mother-to-child transmission of HIV type 1?

Galli L, Puliti D, Chiappini E, Gabiano C, Ferraris G, Mignone F, Viganò A, Giaquinto C, Genovese O, Anzidei G, Badolato R, Buffolano W, Maccabruni A, Salvini F, Cellini M, Ruggeri M, Manzionna M, Bernardi S, Tovo P, de Martino M; Italian Register for HIV Infection in Children..

Clin Infect Dis. 2009 May 1;48(9):1310-7. doi: 10.1086/597774.

PMID:
19309307
8.

Antiretroviral therapy during pregnancy and the risk of an adverse outcome.

Tuomala RE, Shapiro DE, Mofenson LM, Bryson Y, Culnane M, Hughes MD, O'Sullivan MJ, Scott G, Stek AM, Wara D, Bulterys M.

N Engl J Med. 2002 Jun 13;346(24):1863-70.

PMID:
12063370
9.

An effective and safe protocol involving zidovudine and caesarean section to reduce vertical transmission of HIV-1 infection.

Grosch-Wörner I, Schäfer A, Obladen M, Maier RF, Seel K, Feiterna-Sperling C, Weigel R.

AIDS. 2000 Dec 22;14(18):2903-11.

PMID:
11153672
10.

Effect of antiretroviral therapy on pregnancy outcome in HIV-1 positive women.

Kowalska A, Niemiec T, El Midaoui A, Burkacka E.

Med Wieku Rozwoj. 2003 Oct-Dec;7(4 Pt 1):459-68.

PMID:
15010556
11.

Antiretroviral therapy in pregnant women with advanced HIV disease and pregnancy outcomes in Abidjan, Côte d'Ivoire.

Ekouevi DK, Coffie PA, Becquet R, Tonwe-Gold B, Horo A, Thiebaut R, Leroy V, Blanche S, Dabis F, Abrams EJ.

AIDS. 2008 Sep 12;22(14):1815-20. doi: 10.1097/QAD.0b013e32830b8ab9.

PMID:
18753864
12.

Mother-to-child transmission of HIV infection in the era of highly active antiretroviral therapy.

European Collaborative Study..

Clin Infect Dis. 2005 Feb 1;40(3):458-65.

PMID:
15668871
13.

Management of human immunodeficiency virus-infected pregnant women at Latin American and Caribbean sites.

Read JS, Cahn P, Losso M, Pinto J, Joao E, Duarte G, Cardoso E, Freimanis-Hance L, Stoszek SK; NISDI Perinatal Study Group..

Obstet Gynecol. 2007 Jun;109(6):1358-67.

PMID:
17540808
14.

Combination antiretroviral therapy in human immunodeficiency virus-infected pregnant women.

McGowan JP, Crane M, Wiznia AA, Blum S.

Obstet Gynecol. 1999 Nov;94(5 Pt 1):641-6.

PMID:
10546703
15.

Combination antiretroviral therapy in 100 HIV-1-infected pregnant women.

Bucceri AM, Somigliana E, Matrone R, Ferraris G, Rossi G, Grossi E, Vignali M.

Hum Reprod. 2002 Feb;17(2):436-41.

PMID:
11821291
16.

Mother-to-child HIV transmission despite antiretroviral therapy in the ANRS French Perinatal Cohort.

Warszawski J, Tubiana R, Le Chenadec J, Blanche S, Teglas JP, Dollfus C, Faye A, Burgard M, Rouzioux C, Mandelbrot L; ANRS French Perinatal Cohort..

AIDS. 2008 Jan 11;22(2):289-99.

PMID:
18097232
17.
18.

Maternal immune responses and risk of infant infection with HIV-1 after a short course Zidovudine in a cohort of HIV-1 infected pregnant women in rural Kenya.

Makokha EP, Songok EM, Orago AA, Koech DK, Chemtai AK, Kobayashi N, Mpoke S, Tukei PM, Andayi FA, Lihana RW, Adungo NI, Vulule JM.

East Afr Med J. 2002 Nov;79(11):567-73.

PMID:
12630488
19.

Reduction in the risk of vertical transmission of HIV-1 associated with treatment of pregnant women with orally administered zidovudine alone.

Simpson BJ, Shapiro ED, Andiman WA.

J Acquir Immune Defic Syndr Hum Retrovirol. 1997 Feb 1;14(2):145-52.

PMID:
9052723
20.

Maternal antiretroviral drugs during pregnancy and infant low birth weight and preterm birth.

Szyld EG, Warley EM, Freimanis L, Gonin R, Cahn PE, Calvet GA, Duarte G, Melo VH, Read JS; NISDI Perinatal Study Group..

AIDS. 2006 Nov 28;20(18):2345-53.

PMID:
17117021
Items per page

Supplemental Content

Support Center